On Monday, January 20, the next meeting of the AOTMiT Transparency Council.
The agenda includes:
- Preparation of a position paper on the evaluation of the drug Forxiga (dapagliflozinum) for the indication: type 2 diabetes.
- Preparation of a position paper on the evaluation of the drug Verzenios (abemaciclibum) under the drug program B.9.FM. "Treatment of patient...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
If you already have an account, please log in